Harvard Bioscience
HBIO
HBIO
94 hedge funds and large institutions have $84.2M invested in Harvard Bioscience in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 33 increasing their positions, 27 reducing their positions, and 18 closing their positions.
Holders
94
Holders Change
-6
Holders Change %
-6%
% of All Funds
1.36%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
12
Increased
33
Reduced
27
Closed
18
Calls
$2K
Puts
$26K
Net Calls
-$24K
Net Calls Change
-$39K
Top Buyers
| 1 |
AE
1
AMH Equity
Great Neck,
New York
|
$6.43M |
| 2 |
HP
2
Harvey Partners
Tarrytown,
New York
|
$7.3M |
| 3 |
3
Goldman Sachs
New York
|
$472K |
| 4 |
PAM
4
Panagora Asset Management
Boston,
Massachusetts
|
$255K |
| 5 |
5
Morgan Stanley
New York
|
$431K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Squarepoint
New York
| – | – | -19,647 | Closed |
|
|
GI
102
GAMCO Investors
Greenwich,
Connecticut
| – | – | -15,000 | Closed |
|
|
CSS
103
Cubist Systematic Strategies
Stamford,
Connecticut
| – | – | -14,143 | Closed |
|
|
PTC
104
Petrus Trust Company
Dallas,
Texas
| – | – | -13,798 | Closed |
|
|
PCM
105
Portolan Capital Management
Boston,
Massachusetts
| – | – | -12,000 | Closed |
|
106
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | – | -10,015 | Closed |
|
|
PD
107
Point72 (DIFC)
Dubai,
United Arab Emirates
| – | – | -2,428 | Closed |
|
|
IC
108
Innealta Capital
Austin,
Texas
| – | – | -1,671 | Closed |
|
|
PAS
109
Point72 Asia (Singapore)
Singapore
| – | – | -1,664 | Closed |
|
|
SSG
110
Summit Securities Group
New York
| – | – | -310 | Closed |
|
111
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | – | -56 | Closed |
|
|
CFGS
112
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
113
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
FCG
114
Financial Connections Group
Corte Madera,
California
| $0 | 300 | – | – |
|